My most recent transaction, aptly named “YOLO,” has garnered quite a bit of attention, and I have received some excellent questions. I think it is worth exploring some of them here. First, here is the transaction in question: Yes. I bought $31,800 of calls on Apple. Not stocks - call. Options. Derivative products. First, I want […]
Deflation demystified
I have a confession to make: I don’t really like economists. It goes back to my time as as undergrad student, I suppose. I was forced to take three economics classes and I still resent the university for it (no way they are ever getting donations from me). Those were the most dreadful, boring and […]
A disgustingly manipulative article on Freshpet from Ariana Research
A couple of days ago, someone sent me a link to an article about one of the companies I’ve reviewed, FreshPet. The article intrigued me first because the author recommended shorting one of my stock picks, second because he actually recommended shorting a strong and popular IPO operating in a high-growth environment. As I progressed […]
A prayer to Apple, God of the Stock Market
Every night before I go to sleep, I do my prayer to the God Apple: Our Father, Who is in Cupertino, Holy is Your iPhone; Your Apple Stores come, Your products be distributed in China as they are in America Give us this day our daily one dollar stock price increase, and forgive those who short you, as we forgive […]
MOL Global (MOLG): worth buying into this depressed IPO?
Today, while we celebrate the end of one of the most prolific period of IPOs of all times (with Neff today, in which I did not participate), I am starting a new series: Depressed IPO stocks worth buying. In other words, I am going to look at IPOs whose share price fell significantly since their debut and […]
How to make over 300% return with minimal risk (HAL-BHI)
Here’s how to make a quick 400% return with minimal risk thanks to the Halliburton / Baker’s Hughes buyout. Here’s what you’re going to do: When Halliburton buys BHI, you will get 1.12 shares of HAL for every share of BHI you have. You will also get $19.00 in cash. Thus, you are making a […]
The Habit IPO: worth taking a bite?
**Update 11/25: Rebuying as soon as the downtrend ends. It’s at least worth taking a look. The Habit, a fast-growing burger joint based in the United States, is having its IPO this week, probably on Thursday, and it’s by far one of the most popular upcoming IPOs are the moment. In fact, it’s almost […]
Weekly review: Nov 10th - Nov 14th
First, a huge “thank you” to all my new visitors and all their encouragements. It is really appreciated and your support motivates me to keep working and analyzing companies. Thank you to people who posted my website on 4chan and other sources, it is much appreciated. As always, feel more than free to link my […]
Valuing Fibrogen IPO
The IPO I’m waiting for the most at the moment is certainly Fibrogen, a biopharmaceutical company about to become public on Friday. Biopharms have done exceptionally well in the last few months, against all expectations, and I am hoping Fibrogen to be even better. But the question remains: how much is Fibrogen worth? Before we begin, […]
Navios Maritime Midstream: hidden gem or giant gamble?
Navios Maritime Midstream flew under the radar. Even right now, barely anyone discusses it and from the tone of the conversation, you’d believe it’s just another overdone company become public. Yet who would believe Navios Maritime Midstream, or Navios for intimiates, is one of the largest transportation companies? Introduction Do you like big boats? Because […]